Patent · US Active

Compounds

US10555945B2 · kind B2 · utility

2Cited by
12References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2018
Grant dateFeb 11, 2020
Priority date
Expiry dateSep 7, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compounds of formula (I): Said compounds being modulators of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.